Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

This is a one-time financial adjustment related to accounting that has no bearing on ... often prescribed off-label for any type of weight loss. During the quarter, Zepbound became the market ...

The reality, though, is that both drugs are often prescribed off-label for any type of weight loss. During the quarter, Zepbound became ... said it had no interest in negotiating an exclusive ...

In the first quarter, top-line growth is expected to have been driven by demand growth for Lilly’s FDA-approved tirzepatide medicines, diabetes drug Mounjaro and weight loss medicine ...

Unlike others in its class, tirzepatide targets two hormones — glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This double action makes it particularly ...

(AP) — A Michigan school did not violate the free-speech rights of a third-grade student who was told to remove a hat that had an image of an ... included a record label, a fashion brand ...

In a statement, Ro said it will make Zepbound available as a treatment option with an on-label prescription from ... manager CVS Health said it would no longer cover its weight-loss therapy ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...